| Trial ID: | L1948 |
| Source ID: | NCT02426294
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Evidence of efficacy of glycemic control indicated by the mean changes of HbA1c (%) at week 26 from baseline, 26 weeks | Secondary: Evidence of changes of insulin resistance and secretion at week 26 from baseline, Homeostatic model assessment model, 26 weeks|Evidence of changes of Lipid profile at week 26 from baseline, LDL (Low-density lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol and triglyceride, 26 weeks|Evidence of efficacy of glycemic control indicated by the mean changes of HbA1c (%) at week 12 from baseline, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Pusan National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
154
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-02
|
| Completion Date: |
2016-05
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-24
|
| Locations: |
Pusan National University Hospital, Busan, 602-739, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02426294
|
